Literature DB >> 16078117

Nesiritide use for critically ill children awaiting cardiac transplantation.

R Sehra1, K Underwood2.   

Abstract

BACKGROUND: This study aimed to explore the effects of nesiritide in children awaiting cardiac transplantation.
METHODS: At the discretion of the attending physician, nesiritide was added to standard therapy for seven children (median age, 11 months) and continued until clinical improvement or transplantation. Blood pressure and urine output data were compared with data from the day before nesiritide institution. Safety parameters were assessed throughout the study.
RESULTS: Urine output increased from 2.6 to 3.6 ml/kg/h (p = 0.04). No significant blood pressure changes or adverse effects related to nesiritide were noted.
CONCLUSION: Nesiritide may be safe and effective for children with severe heart failure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16078117     DOI: 10.1007/s00246-005-0984-6

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  7 in total

Review 1.  Safety and efficacy of nesiritide for the treatment of decompensated heart failure.

Authors:  Charles L Emerman
Journal:  Rev Cardiovasc Med       Date:  2002       Impact factor: 2.930

Review 2.  Cardiomyopathy and heart transplantation in children.

Authors:  W R Morrow
Journal:  Curr Opin Cardiol       Date:  2000-07       Impact factor: 2.161

3.  Stratification of pediatric heart failure on the basis of neurohormonal and cardiac autonomic nervous activities in patients with congenital heart disease.

Authors:  Hideo Ohuchi; Hisashi Takasugi; Hiroyuki Ohashi; Yoko Okada; Osamu Yamada; Yasuo Ono; Toshikatsu Yagihara; Shigeyuki Echigo
Journal:  Circulation       Date:  2003-11-03       Impact factor: 29.690

4.  The efficacy and safety of B-type natriuretic peptide (nesiritide) in patients with renal insufficiency and acutely decompensated congestive heart failure.

Authors:  Javed Butler; Charles Emerman; W Frank Peacock; Vandana S Mathur; James B Young
Journal:  Nephrol Dial Transplant       Date:  2004-02       Impact factor: 5.992

Review 5.  Acute decompensated heart failure: a contemporary approach to pharmacotherapeutic management.

Authors:  Brian F McBride; C Michael White
Journal:  Pharmacotherapy       Date:  2003-08       Impact factor: 4.705

6.  Preliminary experience with nesiritide in the pediatric population.

Authors:  Julie Marshall; John W Berkenbosch; Pierantonio Russo; Joseph D Tobias
Journal:  J Intensive Care Med       Date:  2004 May-Jun       Impact factor: 3.510

7.  Nesiritide (BNP) in the management of postoperative cardiac patients.

Authors:  Nader Moazami; Ralph J Damiano; Marci S Bailey; Rachel L Hess; Jennifer S Lawton; Marc R Moon; Michael K Pasque
Journal:  Ann Thorac Surg       Date:  2003-06       Impact factor: 4.330

  7 in total
  1 in total

1.  Nesiritide for the treatment of pulmonary hypertension and cor pulmonale in an infant.

Authors:  E W Reynolds; E T Conely; M Vranicar
Journal:  Pediatr Cardiol       Date:  2007-03-20       Impact factor: 1.655

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.